Latest filing published 22 Sept 2008 for Galectin Therapeutics INC, €305.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +33.3%Entry US$1.62 · Close at T+365 US$2.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James Theophile Gourzis: trading record in brief
Only one filing by James Theophile Gourzis is known so far (22 September 2008): an open-market purchase, €305, in Galectin Therapeutics Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James Theophile Gourzis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$0.22Common StockSEC:0001181431-08-054071:0Canonical exit: 18 Dec 2008 (T+90)
1 of 1 declaration
